Antigen-presenting cell vaccine

An antigen-presenting cell vaccine, or an APC vaccine, is a vaccine made of antigens and antigen-presenting cells (APCs).

{{As of|2019|March}}, the only APC vaccine approved by the American Food and Drug Administration is for prostatic acid phosphatase, a commonly over-expressed prostate cancer antigen.{{Cite journal |last=O'Neill |first=David W. |date=November 2010 |title=Dendritic cells and T cells in immunotherapy |url=https://pubmed.ncbi.nlm.nih.gov/21061761 |journal=Journal of Drugs in Dermatology |volume=9 |issue=11 |pages=1383–1392 |issn=1545-9616 |pmid=21061761}}{{Cite book |author1=Marc S. Ernstoff |url=https://books.google.com/books?id=Q0dvDwAAQBAJ |title=SITC's Guide to Managing Immunotherapy Toxicity |author2=Igor Puzanov |author3=Caroline Robert |author4=Adi M. Diab |author5=Peter M. Hersey |date=2019-03-15 |publisher=Springer Publishing Company |isbn=978-0-8261-7215-0 |pages=xviii |language=en}}